Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.

Literature DB >> 34911281

Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.

Kevin S Tanager¹, Jovian Yu², Brian C-H Chiu³, Timothy C Carll¹, Alexandra H Tatarian⁴, Peter Riedell², Sonali Smith², Justin Kline², Girish Venkataraman⁵.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2022 PMID： 34911281 PMCID： PMC8968890 DOI： 10.3324/haematol.2021.279648

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

Keyword Cloud
References

× No keyword cloud information.

12 in total

1. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

Authors: Kelly Moran-Crusio; Linsey Reavie; Alan Shih; Omar Abdel-Wahab; Delphine Ndiaye-Lobry; Camille Lobry; Maria E Figueroa; Aparna Vasanthakumar; Jay Patel; Xinyang Zhao; Fabiana Perna; Suveg Pandey; Jozef Madzo; Chunxiao Song; Qing Dai; Chuan He; Sherif Ibrahim; Miloslav Beran; Jiri Zavadil; Stephen D Nimer; Ari Melnick; Lucy A Godley; Iannis Aifantis; Ross L Levine
Journal: Cancer Cell Date: 2011-06-30 Impact factor: 31.743

Review 2. Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma.

Authors: Akito Dobashi
Journal: J Clin Exp Hematop Date: 2016

3. Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.

Authors: François Lemonnier; Elsa Poullot; Aurélie Dupuy; Lucile Couronné; Nadine Martin; Laurianne Scourzic; Virginie Fataccioli; Julie Bruneau; Rob A Cairns; Tak W Mak; Olivier A Bernard; Laurence de Leval; Philippe Gaulard
Journal: Haematologica Date: 2017-12-14 Impact factor: 9.941

4. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.

Authors: Brian C-H Chiu; Zhou Zhang; Qiancheng You; Chang Zeng; Elizabeth Stepniak; Paige M Bracci; Kangkang Yu; Girish Venkataraman; Sonali M Smith; Chuan He; Wei Zhang
Journal: Blood Adv Date: 2019-10-08

5. TET1 is a tumor suppressor of hematopoietic malignancy.

Authors: Luisa Cimmino; Meelad M Dawlaty; Delphine Ndiaye-Lobry; Yoon Sing Yap; Sofia Bakogianni; Yiting Yu; Sanchari Bhattacharyya; Rita Shaknovich; Huimin Geng; Camille Lobry; Jasper Mullenders; Bryan King; Thomas Trimarchi; Beatriz Aranda-Orgilles; Cynthia Liu; Steven Shen; Amit K Verma; Rudolf Jaenisch; Iannis Aifantis
Journal: Nat Immunol Date: 2015-04-13 Impact factor: 25.606

6. B-cell tumor development in Tet2-deficient mice.

Authors: Enguerran Mouly; Hussein Ghamlouch; Veronique Della-Valle; Laurianne Scourzic; Cyril Quivoron; Damien Roos-Weil; Patrycja Pawlikowska; Véronique Saada; M'Boyba K Diop; Cécile K Lopez; Michaela Fontenay; Philippe Dessen; Ivo P Touw; Thomas Mercher; Said Aoufouchi; Olivier A Bernard
Journal: Blood Adv Date: 2018-03-27

7. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.

Authors: Ikuo Matsuda; Yukihiro Imai; Seiichi Hirota
Journal: J Clin Exp Hematop Date: 2014